Search Results
(±)5-HEPE 100 µg | ≥97%
Cayman Chemical
(±)5-HEPE 50 µg | ≥97%
Cayman Chemical
(±)5-HEPE 25 µg | ≥97%
Cayman Chemical
(±)5-HEPE 1 mg | Purity Not Available
TargetMol
(±)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE. The biological activity of (±)5-HEPE is likely mediated by one of the individual isomers, most commonly the 5(S) isomer in mammalian systems. EPA can be metabolized to 5-HEPE in human and bovine neutrophils, and human eosinophils, which is further […]
More Information Supplier Page(±)5-HEPE 1mg | ≥98%
Musechem
(±)5-HETE 100 µg | ≥95%
Cayman Chemical
A monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid
More Information Supplier Page(±)5-HETE 50 µg | ≥95%
Cayman Chemical
A monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid
More Information Supplier Page(±)5-HETE 25 µg | ≥95%
Cayman Chemical
A monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid
More Information Supplier Page(±)5-HETE 1 mg | Purity Not Available
TargetMol
(±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. It contains equal amounts of 5(S)-HETE and 5(R)-HETE. (±)5-HETE induces the aggregation of isolated neutrophils with an IC50 value of 200 nM.[1]
More Information Supplier Page

